APAS

(redirected from Antiphospholipid antibody syndrome)
Also found in: Medical.
Category filter:
AcronymDefinition
APASAntiphospholipid Antibody Syndrome
APASAustralian Paint Approval Scheme (Commonwealth Scientific & Industrial Research Organisation; Australia)
APASAstrophysical Planetary and Atmospheric Sciences
APASAndrogynous Peripheral Assembly System (NASA)
APASAsian Pacific American Society (New Orleans, LA)
APASAndrogynous Peripheral Attachment System
APASAerodynamic Preliminary Analysis System
APASAllegheny Plateau Audubon Society (Pennsylvania)
APASAnimal Protective Association of Socorro (New Mexico)
APASAssistant Professor of Aerospace Studies
APASAutomated Pilot Advisory System
APASActive Passive Aircraft Survivability
APASAutomated Plutonium Assay System
APASAdvanced Passive Array Sonobuoy
APASAll Purpose Accounting System
APASAdvanced Passive Sensor
APASAutomatic Performance Analysis
APASAnalyst Projection Assistance System (US Army)
APASAndhra Pradesh Administrative Service (India)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Antiphospholipid antibody syndrome (APS) is an autoimmune disease associated with elevated titres of antiphospholipid antibodies (aPL) [55].
Patients with antiphospholipid antibody syndrome (APS) were not excluded in this study [4] Thrombocytopenia is a well-known manifestation of APS which occurs more frequently in patients with APS associated with SLE [5, 6].
Additional recommendations included outpatient follow-up with the hematology/oncology clinic for continued evaluation of a possible coagulation disorder, given the presence of antiphospholipid antibody syndrome in a first-degree relative.
Tefferi, "Use of fondaparinux in a patient with antiphospholipid antibody syndrome and heparin-associated thrombocytopenia," Journal of Thrombosis and Haemostasis, vol.
(4) Spontaneous right-sided heart thrombi have been detected in hypercoagulability states such as protein C deficiency, Bencher's disease, (5, 6) inflammatory bowel disease, (7) and antiphospholipid antibody syndrome and rarely in SCD due to thrombotic microangiopathic processes.
A 63-year-old woman with history of connective tissue disorder on hydroxychloroquine 200mg oral once a day for three months and antiphospholipid antibody syndrome presented with insidious onset of dyspnea and orthopnea of six weeks duration.
Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin.
Prevalence and Pattern of Antiphospholipid Antibody Syndrome in a Hospital Based Longitudinal Study of 193 Patients of Sytemic Lupus Erythematosus.
The most common cause of digital gangrene associated with SLE is antiphospholipid antibody syndrome (AAS), and SLE is the leading cause of secondary AAS.
Antiphospholipid antibody syndrome (APS) is a systemic, autoimmune, acquired disorder characterized by venous and/or arterial thrombosis and/or pregnancy morbidities, associated with the positivity, confirmed at least in two occasions 12 weeks apart, of such autoantibodies directed toward molecular complexes of phospholipids and proteins.